Author Index: O
• MULTI-CRITERIA DECISION ANALYSIS: USEFUL, BUT NOT A SUITABLE REPLACEMENT FOR COST-EFFECTIVENESS ANALYSIS
• DECISION RULES FOR VALUE-BASED REIMBURSEMENT: MOVING ON FROM NET HEALTH BENEFIT
• THE DETERMINANTS OF CHANGE IN THE COST-EFFECTIVENESS THRESHOLD
• TEN WAYS TO ENHANCE THE ESTIMATION, REPORTING AND INTERPRETATION OF THE COST-EFFECTIVENESS OF CANCER SCREENING INTERVENTIONS
• DECISION RULES FOR VALUE-BASED REIMBURSEMENT: MOVING ON FROM NET HEALTH BENEFIT
• THE DETERMINANTS OF CHANGE IN THE COST-EFFECTIVENESS THRESHOLD
• TEN WAYS TO ENHANCE THE ESTIMATION, REPORTING AND INTERPRETATION OF THE COST-EFFECTIVENESS OF CANCER SCREENING INTERVENTIONS
• IMPROVING CERVICAL CANCER PRIMARY SCREENING AND DIAGNOSTIC FOLLOW-UP IN AUSTRIA – A DECISION-ANALYTIC BENEFIT-HARM ANALYSIS
• HEALTH-ECONOMIC EVALUATION OF HPV-BASED CERVICAL CANCER PRIMARY SCREENING COMPARED TO CYTOLOGY OR P16/KI-67 DUAL-STAINING – A DECISION-ANALYSIS FOR THE AUSTRIAN HEALTH CARE CONTEXT
• THE BENEFIT-HARM BALANCE OF PROSTATE CANCER SCREENING IN MEN WITH AVERAGE AND ELEVATED FAMILIAL RISK – PREDICTIONS OF THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL
• HEALTH-ECONOMIC EVALUATION OF HPV-BASED CERVICAL CANCER PRIMARY SCREENING COMPARED TO CYTOLOGY OR P16/KI-67 DUAL-STAINING – A DECISION-ANALYSIS FOR THE AUSTRIAN HEALTH CARE CONTEXT
• THE BENEFIT-HARM BALANCE OF PROSTATE CANCER SCREENING IN MEN WITH AVERAGE AND ELEVATED FAMILIAL RISK – PREDICTIONS OF THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL